Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management
Open Access
- 10 February 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 683
Abstract
Knowledge on heparin-induced thrombocytopenia keeps increasing. Recent progress on diagnosis and management as well as several discoveries concerning its pathogenesis have been made. However, many aspects of heparin-induced thrombocytopenia remain partly unknown, and exact application of these new insights still need to be addressed. This article reviews the main new concepts in pathogenesis, diagnosis, and management of heparin-induced thrombocytopenia.Keywords
This publication has 99 references indexed in Scilit:
- PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRIBlood, 2012
- Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patientsHaematologica, 2011
- Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopeniaBlood, 2010
- Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantationBlood, 2008
- Contaminated HeparinNew England Journal of Medicine, 2008
- Immune complexes formed following the binding of anti–platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesionBlood, 2008
- Determinants of PF4/heparin immunogenicityBlood, 2007
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxNew England Journal of Medicine, 2007
- Heparin‐induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassemblyJournal of Clinical Apheresis, 2007
- The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexesBlood, 2004